234 related articles for article (PubMed ID: 15582072)
1. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term.
Baudouin C; Hamard P; Liang H; Creuzot-Garcher C; Bensoussan L; Brignole F
Ophthalmology; 2004 Dec; 111(12):2186-92. PubMed ID: 15582072
[TBL] [Abstract][Full Text] [Related]
2. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways.
Baudouin C; Liang H; Hamard P; Riancho L; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
Ophthalmology; 2008 Jan; 115(1):109-15. PubMed ID: 17532048
[TBL] [Abstract][Full Text] [Related]
3. [Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments].
Bensoussan L; Blondin C; Baudouin C; Hamard P; Sabeh Afaki G; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
J Fr Ophtalmol; 2003 Oct; 26(8):782-9. PubMed ID: 14586218
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.
Brignole F; Pisella PJ; Goldschild M; De Saint Jean M; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1356-63. PubMed ID: 10798650
[TBL] [Abstract][Full Text] [Related]
5. [Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients].
Pisella PJ; Lala E; Parier V; Brignole F; Baudouin C
J Fr Ophtalmol; 2003 Sep; 26(7):675-9. PubMed ID: 13130254
[TBL] [Abstract][Full Text] [Related]
6. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2444-50. PubMed ID: 15980234
[TBL] [Abstract][Full Text] [Related]
7. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study.
Pisella PJ; Debbasch C; Hamard P; Creuzot-Garcher C; Rat P; Brignole F; Baudouin C
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1360-8. PubMed ID: 15111589
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD40 and CD40 ligand in the human conjunctival epithelium.
Bourcier T; De Saint-Jean M; Brignole F; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):120-6. PubMed ID: 10634610
[TBL] [Abstract][Full Text] [Related]
9. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies.
Baudouin C; Pisella PJ; Fillacier K; Goldschild M; Becquet F; De Saint Jean M; Béchetoille A
Ophthalmology; 1999 Mar; 106(3):556-63. PubMed ID: 10080214
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
Brignole F; Pisella PJ; De Saint Jean M; Goldschild M; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers.
Manni G; Centofanti M; Oddone F; Parravano M; Bucci MG
Am J Ophthalmol; 2005 Jan; 139(1):72-7. PubMed ID: 15652830
[TBL] [Abstract][Full Text] [Related]
12. Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders.
Brignole F; De Saint-Jean M; Goldschild M; Becquet F; Goguel A; Baudouin C
Exp Eye Res; 1998 Dec; 67(6):687-97. PubMed ID: 9990333
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation.
Baudouin C; Brignole F; Becquet F; Pisella PJ; Goguel A
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1458-64. PubMed ID: 9191610
[TBL] [Abstract][Full Text] [Related]
14. CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1/ T(H)2 in ocular surface disorders.
Baudouin C; Liang H; Bremond-Gignac D; Hamard P; Hreiche R; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
J Allergy Clin Immunol; 2005 Sep; 116(3):614-9. PubMed ID: 16159632
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment.
Rodrigues Mde L; Felipe Crosta DP; Soares CP; Deghaide NH; Duarte R; Sakamoto FS; Furtado JM; Paula JS; Donadi EA; Soares EG
J Glaucoma; 2009 Mar; 18(3):197-200. PubMed ID: 19295371
[TBL] [Abstract][Full Text] [Related]
16. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I; Motolese E
Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
[TBL] [Abstract][Full Text] [Related]
17. Th1 and Th2 responses on the ocular surface in uveitis identified by CCR4 and CCR5 conjunctival expression.
Trinh L; Brignole-Baudouin F; Raphaël M; Dupont-Monod S; Cassoux N; Lehoang P; Baudouin C
Am J Ophthalmol; 2007 Oct; 144(4):580-5. PubMed ID: 17686449
[TBL] [Abstract][Full Text] [Related]
18. The role of conjunctival epithelial cells in chronic ocular allergic disease.
Hingorani M; Calder VL; Buckley RJ; Lightman SL
Exp Eye Res; 1998 Nov; 67(5):491-500. PubMed ID: 9878210
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
Avunduk AM; Tekelioglu Y; Turk A; Akyol N
Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
[TBL] [Abstract][Full Text] [Related]
20. [Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].
Nenciu A; Stefan C; Ardelean C
Oftalmologia; 2004; 48(1):35-42. PubMed ID: 15279417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
